Watson Pharmaceuticals Inc.

United States
Company NameWatson Pharmaceuticals Inc.
PI Number19
Revenue (Millions)$4,584
Total Equity (Millions)$3,564
Net Income (Millions)$261
Revenue Growth28.53%
Profit Margin 15.69%
Earnings per Share$2.06
Debt to Equity Ratio0.19%
Return on Equity7.95%
Cost of Goods Sold (Millions)$2,565
Earnings per Share Growth39.19%
Total Assets (Millions)$6,698
Current Liabilities (Millions)$1,840
Long Term Debt (Millions)$665